The FDA has a new warning about GLP-1s and vision loss. Should you worry?The Washington Post's live-updates page leads with the FDA's new rule requiring GLP-1 labels to warn of a potential vision-loss risk, which ophthalmologist Manjot Gill calls very rare and says is outweighed by the drugs' benefits. Its other items include Jensen Huang's affair admission, Cranbury Township's $26 million theft, the U.S.'s imperiled measles-elimination status, Karen Read's $100,000 settlement, Sen. John Cornyn's exit, and a potential nor'easter.